Resultados de procura - Anna Galkin

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

    GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors por David G. DeNardo, Anna Galkin, Jakob Dupont, Lei Zhou, Johanna C. Bendell

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Epithelial membrane protein-1 is a biomarker of gefitinib resistance

    Epithelial membrane protein-1 is a biomarker of gefitinib resistance por Anjali Jain, Charles Tindell, Isett Laux, Jacob B. Hunter, John A. Curran, Anna Galkin, Daniel Afar, Nina Aronson, Steven Shak, Ronald B. Natale, David B. Agus

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension

    Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension por Anna Galkin, Ravikumar Sitapara, Bryan Clemons, E. Garcı́a, Michael Kennedy, David M. Guimond, Laura Carter, Ashley J. Douthitt, Robin Osterhout, Aneta Gandjeva, Deborah H. Slee, Luisa Salter–Cid, Rubin M. Tuder, Lawrence S. Zisman

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    A genomic screen identifies TYRO3 as a MITF regulator in melanoma

    A genomic screen identifies TYRO3 as a MITF regulator in melanoma por Shoutian Zhu, Heiko Wurdak, Yan Wang, Anna Galkin, Hai‐Yan Tao, Jie Li, Costas A. Lyssiotis, Feng Yan, Buu P. Tu, Loren Miraglia, John R. Walker, Fanxiang Sun, Anthony P. Orth, Peter G. Schultz, Xu Wu

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

    Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK por Anna Galkin, Jonathan S. Melnick, Sung Joon Kim, Tami Hood, Nanxin Li, Lintong Li, Gang Xia, Ruo W. Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Peter Ding, Yi Liu, Fangxian Sun, Peter G. Schultz, Nathanael S. Gray, Markus Warmuth

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity

    Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity por Xiuting Liu, Graham D. Hogg, Chong Zuo, Nicholas Borcherding, John Baer, Varintra E. Lander, Liang‐I Kang, Brett L. Knolhoff, Faiz Ahmad, Robin Osterhout, Anna Galkin, Jean‐Marie Bruey, Laura Carter, Cedric Mpoy, Kiran Vij, Ryan C. Fields, Julie K. Schwarz, Haeseong Park, Vineet Gupta, David G. DeNardo

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: